06/07/2024
3:42 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:52 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:36 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
6:37 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/09/2024
6:05 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:12 AM | Amylyx Pharmaceuticals (Filer)
| Form DEFA14A | |
04/24/2024
6:19 AM | Amylyx Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form DEF 14A | |
04/18/2024
7:19 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:21 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/18/2024
7:23 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
8:19 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:31 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/15/2024
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2024
8:18 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
7:44 AM | Amylyx Pharmaceuticals (Subject)
Panacea Innovation Ltd (Filed by)
| Form SC 13G | |
03/08/2024
6:10 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
5:44 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:13 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:20 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
5:22 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
7:22 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:08 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:36 PM | Amylyx Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
9:24 AM | Amylyx Pharmaceuticals (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
6:15 AM | Amylyx Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | Amylyx Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
01/29/2024
3:38 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
3:50 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:04 PM | Amylyx Pharmaceuticals (Issuer)
Yeramian Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:10 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:11 PM | Amylyx Pharmaceuticals (Issuer)
Klee Justin B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:37 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
12/07/2023
6:00 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2023
3:45 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/29/2023
3:49 PM | Amylyx Pharmaceuticals (Issuer)
Bedrosian Camille L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:20 PM | Amylyx Pharmaceuticals (Issuer)
Cohen Joshua B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2023
5:58 AM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:07 AM | Amylyx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
2:33 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/13/2023
4:20 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
3:19 PM | Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
| Form SC 13D/A | |
08/24/2023
3:15 PM | Amylyx Pharmaceuticals (Issuer)
FRATES JAMES M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:34 PM | Amylyx Pharmaceuticals (Issuer)
Morningside Venture Investments Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
4:15 PM | Amylyx Pharmaceuticals (Subject)
Morningside Venture Investments Ltd (Filed by)
| Form SC 13D/A | |
08/17/2023
3:35 PM | Amylyx Pharmaceuticals (Issuer)
Mazzariello Gina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:20 PM | Amylyx Pharmaceuticals (Issuer)
Olinger Margaret (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
4:16 PM | Amylyx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
6:50 PM | Amylyx Pharmaceuticals (Issuer)
Firestone Karen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:39 PM | Amylyx Pharmaceuticals (Issuer)
Quimi Daphne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:46 PM | Amylyx Pharmaceuticals (Issuer)
MILNE GEORGE M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2023
6:34 PM | Amylyx Pharmaceuticals (Issuer)
FONTEYNE PAUL R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
